Name | Pediatrics |
---|---|
Chairman |
Professor Takashi Hamazaki
|
Contact |
Phone:+81-6-6645-3816 Email:ped@med.osaka-cu.ac.jp |
Contact | http://www.med.osaka-cu.ac.jp/pediat/ |
Overview |
The Department of Pediatrics was established within Osaka City University School of Medicine in 1944. Our Department of Pediatrics provides care for children in the areas of emergency medicine, genetics and inborn errors of metabolism, cardiology, hematology/oncology, neonatology, infectious diseases, neurology, gastrointestinal disorders, diabetes and endocrinology. We are working to improve the health of all children in our community and to advance child health through research. We strive to provide education, training experience and scientific research to students and young physicians and to prepare future leaders in pediatric medicine. In our research activities, we aim to play a significant role in leading worldwide studies in the diagnosis and treatment of inborn errors of metabolism. Recently, we obtained four grants from the Ministry of Health, Labor and Welfare, four grants from the Japan Agency for Medical Research and Development (AMED), and a training grant from the Ministry of Education, Culture, Sports, Science and Technology. In recent years, we have made great achievements in patient identification and development of cures for inborn errors of metabolism using induced pluripotent stem cells and PET. We have contributed to research on intractable diseases by the Ministry of Health, Labor and Welfare. We have created guidelines for diagnosis and developed a new cure for rare disorders through the national survey of Pediatric Neurotransmitter Disease. We also started a new strategy of treatment providing autologous cord blood cells to infants with hypoxic ischemic encephalopathy for the first time in Japan in 2014 by supporting the regenerative medicine program of AMED, and we have pushed forward development of the highest quality system of newborn management. We also started an intensive course to train physicians to provide home care for seriously ill children in 2015. We established a graduate school for this course in 2016 with support from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Our group is one of the pioneers in the treatment of diabetes by using an insulin pump to help patients manage their diabetes. We introduced the capsule endoscope and FibroScan into pediatrics for the first time in Japan and we built up the medical treatment system in pediatrics. In these ways, we have advanced medical treatment and research to contribute to pediatric development in each specialty. |